Related Experiment Videos
Surrogate end points in cardiovascular disease trials
1Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.
American Heart Journal
|March 31, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A simulation study evaluating bio-creep risk in serial non-inferiority clinical trials for preservation of effect.
Statistics in biopharmaceutical research·2015
Design, conduct, and analysis of clinical trials in disease due to methicillin-resistant Staphylococcus aureus.
Clinical pharmacology and therapeutics·2009
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses.
Multiple sclerosis (Houndmills, Basingstoke, England)·2008
Evaluating the safety of interventions for prevention of perinatal transmission of HIV.
Annals of the New York Academy of Sciences·2000
Safety and toxicity of nonoxynol-9 gel as a rectal microbicide.
Sexually transmitted diseases·1999
From Electrical Morphology to Physiological Dynamics: Lessons From ECG Adoption for the Clinical Integration of Heart Rate Variability.
European journal of clinical investigation·2026
Congenital heart defect (CHD)-related telehealth and other outpatient utilization among Medicaid and private insurance beneficiaries: 2018-2023.
Journal of telemedicine and telecare·2026
Complement System in Bone Inflammation and Autoimmunity.
Journal of leukocyte biology·2026